Aytu BioPharma, Inc.

AYTU · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$30,952$20,006$22,985$19,360
Short-Term Investments$0$0$0$0
Receivables$31,155$23,526$28,937$21,712
Inventory$11,434$12,141$11,995$10,849
Other Curr. Assets$0$1,121$868$633
Total Curr. Assets$79,179$61,891$72,832$59,929
Property Plant & Equip (Net)$1,593$1,522$3,869$6,296
Goodwill$0$0$0$0
Intangibles$42,201$52,453$58,970$70,632
Long-Term Investments$0$0$0$0
Tax Assets$0$762$1,378$0
Other NC Assets$1,204$2,229$792$766
Total NC Assets$44,998$56,966$65,009$77,694
Other Assets$0$0$0$0
Total Assets$124,177$118,857$137,841$137,623
Liabilities
Payables$10,601$10,314$13,478$10,987
Short-Term Debt$10,920$4,964$8,738$3,813
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$26,145$42,347$41,124$23,840
Total Curr. Liab.$63,064$62,228$69,015$64,442
LT Debt$10,895$10,877$20,856$14,195
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$762$1,378$0
Other NC Liab.$30,267$16,697$6,403$14,594
Total NC Liab.$42,147$28,913$29,469$28,873
Other Liabilities$0$0$0$0
Cap. Leases$1,122$0$832$180
Total Liabilities$105,211$91,141$98,484$93,315
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$0
Retained Earnings-$333,535-$319,973-$304,129-$287,078
AOCI$0$0$0-$0
Other Equity$0$0$0$0
Total Equity$18,966$27,716$39,357$44,308
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$124,177$118,857$137,841$137,623
Net Debt-$9,137-$4,165$6,609-$1,352
Aytu BioPharma, Inc. (AYTU) Financial Statements & Key Stats | AlphaPilot